pmc logo image
Logo of canmedajCMAJ home pageCMAJ information for authors page

Formats:

Can Med Assoc J. 1980 April 19; 122(8): 881–884.
PMCID: PMC1801634
Rhinitis medicamentosa.
M. J. Black and K. A. Remsen
Abstract
Rhinitis medicamentosa, the syndrome of rebound nasal congestion secondary to prolonged topical intranasal use of vasoconstrictors, is reviewed. In this condition, the nasal airway is very obstructed; atrophic rhinitis is the most serious complication. Management consists of withdrawing the offending nasal spray and alleviating the nasal obstruction by means of any of several treatment modalities.
Full text
Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (882K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
  • Oliver G, Schäfer EA. The Physiological Effects of Extracts of the Suprarenal Capsules. J Physiol. 1895 Jul 18;18(3):230–276. [PubMed]
  • Barger G, Dale HH. Chemical structure and sympathomimetic action of amines. J Physiol. 1910 Oct 11;41(1-2):19–59. [PubMed]
  • Stride RD. Nasal decongestant therapy. Br J Clin Pract. 1967 Nov 11;21(11):541–548. [PubMed]
  • Blue JA. Rhinitis medicamentosa. Ann Allergy. 1968 Aug;26(8):425–429. [PubMed]
  • Baldwin RL. Rhinitis medicamentosa (an approach to treatment). J Med Assoc State Ala. 1975 Aug;47(2):33–35. [PubMed]
  • Wilensky JT, Woodward HJ. Acute systemic hypertension after conjunctival instillation of phenylephrine hydrochloride. Am J Ophthalmol. 1973 Jul;76(1):156–157. [PubMed]
  • Cass E, Kadar D, Stein HA. Hazards of phenylephrine topical medication in persons taking propranolol. Can Med Assoc J. 1979 May 19;120(10):1261–1262. [PubMed]
  • WALKER JS. Rhinitis medicamentosa. J Allergy. 1952 Mar;23(2):183–186. [PubMed]